➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Moodys
McKinsey
Baxter
Colorcon
Mallinckrodt

Last Updated: August 7, 2020

DrugPatentWatch Database Preview

CORTENEMA Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Cortenema, and what generic alternatives are available?

Cortenema is a drug marketed by Ani Pharms and is included in one NDA.

The generic ingredient in CORTENEMA is hydrocortisone. There are sixty-seven drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the hydrocortisone profile page.

US ANDA Litigation and Generic Entry Outlook for Cortenema

A generic version of CORTENEMA was approved as hydrocortisone by IMPAX LABS INC on March 30th, 2007.

  Start Trial

Drug patent expirations by year for CORTENEMA
Drug Prices for CORTENEMA

See drug prices for CORTENEMA

Recent Clinical Trials for CORTENEMA

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Cancer Institute (NCI)Phase 1
Children's Oncology GroupPhase 3
Cristcot LLCPhase 1

See all CORTENEMA clinical trials

Pharmacology for CORTENEMA

US Patents and Regulatory Information for CORTENEMA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms CORTENEMA hydrocortisone ENEMA;RECTAL 016199-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Merck
Medtronic
Johnson and Johnson
AstraZeneca
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.